Stocktoria
AVAI BIO, INC. AVAI
OTC · OOTC · stock
AVAI BIO, INC. financials (annual, from 10-K)
Bars are annual figures from 2019 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $276,324 | — | — | — | — |
| Gross profit | — | — | — | -$40,453 | $210,794 | -$16,536 | $256,334 | $0 |
| R&D expense | — | — | — | — | — | — | $27,040 | $0 |
| Operating income | -$1.1M | -$2.1M | — | -$348,933 | $126,521 | $302,292 | -$69,593 | -$78,225 |
| Net income | -$1.1M | -$2.1M | -$1.8M | -$348,933 | — | -$248,022 | -$69,593 | -$78,225 |
| Operating cash flow | -$1.2M | -$1.3M | — | -$54,457 | $535,008 | -$16,169 | $130,718 | -$84,165 |
| Cash & equivalents | $81,053 | $281 | $896 | $107,472 | $33,289 | $60,364 | $27,301 | $102 |
| Total assets | $224,745 | $322,014 | $291,246 | $241,460 | $454,664 | $816,269 | $419,971 | $30,523 |
| Total liabilities | $1.8M | $1.8M | $1.7M | $874,719 | $860,225 | $1.1M | -$37,686 | $30,523 |
| Shareholders' equity | -$1.6M | -$1.5M | -$1.4M | -$633,259 | -$405,561 | -$327,413 | -$37,686 | -$49,612 |
Source: SEC EDGAR filings · CIK 0001740797 · US · as of 2025-03-31. facts plus Stocktoria's own computed scores — not investment advice.